Drug targets and Drug Delivery

The expression "biological target" is mostly used as a part of pharmaceutical research to depict the native protein in the body whose movement is modified by a drug resulting in a particular impact, which might be an alluring therapeutic impact or an undesirable antagonistic impact. In this specific circumstance, the biological target is usually referred to as a Drug target. Distinguishing the biological origin of a disease, and the potential focuses for intervention, is the initial phase in the discovery of a drug utilizing the reverse pharmacology approach. Various diverse target discovery approaches have been recognized, for example, drug affinity responsive target stability (DARTS).

  • Drug Interactions
  • Ligand Based Drug Design
  • Scoring functions
  • Structure Based Drug Design
  • Protein crystallography in drug discovery
  • Molecular modeling in drug design
  • Cancer drug design and discovery
  • Drug design strategies
  • Transformative concepts for drug design

Related Conference of Drug targets and Drug Delivery

December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy
July 14-15, 2025

15th World Glycobiology Congress

Berlin, Germany
September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany

Drug targets and Drug Delivery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in